ABSTRACT: Uterine and placental infections are the leading cause of abortion, stillbirth, and preterm delivery in the mare. Whereas uterine and placental infections in women have been studied extensively, a comprehensive examination of the pathogenic processes leading to this unsatisfactory pregnancy outcome in the mare has yet to be completed. Most information in the literature relating to late-term pregnancy loss in mares is based on retrospective studies of clinical cases submitted for necropsy. Here we report the development and application of a novel approach, whereby transgenically modified bacteria transformed with lux genes of Xenorhabdus luminescens or Photorhabdus luminescens origin and biophotonic imaging are utilized to better understand pathogen-induced preterm birth in late-term pregnant mares. This technology uses highly sensitive bioluminescence imaging camera systems to localize and monitor pathogen progression during tissue invasion by measuring the bioluminescent signatures emitted by the lux-modified pathogens. This method has an important advantage in that it allows for the potential tracking of pathogens in vivo in real time and over time, which was hitherto impossible. Although the application of this technology in domestic animals is in its infancy, investigators were successful in identifying the fetal lungs, sinuses, nares, urinary, and gastrointestinal systems as primary tissues for pathogen invasion after experimental infection of pregnant mares with lux-modified Escherichia coli. It is important that pathogens were not detected in other vital organs, such as the liver, brain, and cardiac system. Such precision in localizing sites of pathogen invasion provides potential application for this novel approach in the development of more targeted therapeutic interventions for pathogen-related diseases in the equine and other domestic species.
INTRODUCTION
Premature birth is the leading cause of prenatal morbidity in humans, with an incidence of 12.5% (Behrman and Butler, 2006) , of which 40% may be attributed to antenatal infection (Lettieri et al., 1993) , with Escherichia coli being identified as the most common organism isolated from pregnant women (Lavanya and Jogalakshmi, 2002) . In cattle, the rate of uterine infection has been estimated at 2.2 to 37.3% (Kelton et al., 1998) , with E. coli being the most commonly isolated bacteria associated with postpartum uterine infections. Similarly, placental infection attributable to opportunistic pathogens such as Streptococcus equi ssp. zooepidemicus and E. coli are common causes of abortion, stillbirth, and premature delivery in horses (Whitwell, 1988; Giles et al., 1993; Hong et al., 1993a,b) . Moreover, pathogen progression during uterine infections and placentitis may involve invasion of endometrial and fetal tissues, leading to an increased expression of proinflammatory cytokines, resulting in the onset of premature delivery, fetal neurological damage, or both (Hillier et al., 1993; Duggan et al., 2001; Behrman, 2006) . Although animal models, such as the rhesus monkey (Gravett et al., 1994) and rodents (Bennett et al., 2000; Terrone et al., 2001) , have been used to understand pathogeninduced preterm labor in women, little is known about bacterial pathogenesis during uterine infections in the equid species. Thus, the intent of this paper was to discuss a novel approach that uses real-time bioluminescence imaging technology to elucidate the pathogenesis of uterine bacterial infections associated with preterm birth in the mare. An overview of uterine infections and background information on bioluminescence imaging, lux-modified bacteria, and their application in other living systems is provided in support of the discussion. Although this technology is used extensively in the field of biomedical research, mainly using the murine infection model, it is in its infancy in the field of animal science because of the significant logistical and biohazard challenges encountered.
UTEROPLACENTAL INFECTIONS, PREGNANCY LOSS, AND NEONATAL MORTALITY
It is well documented that uterine infection is highly correlated with idiopathic preterm labor (Hillier et al., 1993; Dudley 1997; Romero et al., 1998 Romero et al., , 2010 MazakiTovi et al., 2010) , which is the leading cause of neonatal mortality and morbidity in humans (Gotsch et al., 2009; Shah et al., 2009) . Moreover, infants that do survive have a greater likelihood of developing other disorders in early life (Butt et al., 2006; Pereira et al., 2007; Shah et al., 2009) . Similarly, Giles et al. (1993) reported, based on the pathology records of horses, that 60% of fetal abortions, stillbirths, and foal deaths within 24 h of birth were associated with placental insufficiency, of which one-third were associated with placental infections. Among the many cases examined, the most common pathogens isolated from aborted fetuses or dead perinatal foals were the opportunistic S. equi ssp. zooepidimicus, E. coli, or both (Giles et al., 1993; Hong et al., 1993a,b) . The etiology of uterine infectioninduced preterm delivery in pregnant women, mice, and mares involves the release of proinflammatory cytokines, such as tumor necrosis factor α (TNFα), IL-1β, IL-6, and IL-8, among others, from placental and fetal tissues in response to infection (Dudley and Trautman, 1994; Pollard and Mitchell, 1996; Dudley, 1997; Mussalli et al., 1999; LeBlanc et al., 2002) . The consequence of the inappropriate expression of these proinflammatory cytokines leads to the initiation of a preterm birth by increasing PG synthesis (Bennett et al., 2000; LeBlanc et al., 2002; McGlothlin et al., 2004) .
As in humans, pregnancy loss during late gestation and the death of foals weakened by abnormal periparturient events constitute a large percentage of fetal and neonatal mortality in horses (Vaala and Sertich, 1994) , and pluriparous mares are the most commonly afflicted (LeBlanc, 2010) . Premature birth in horses usually results in the delivery of a nonviable foal because complete fetal maturation for successful extrauterine life does not occur until the final 5 to 7 d of development in utero (Silver and Fowden, 1994) . Because of the expense of breeding contracts and the long gestation of the mare, late-term fetal death represents a major financial loss and time investment for the breeder. Early identification of placental insufficiency may make it possible to sustain the pregnancy through medical intervention. However, at this time, a full understanding of the pathophysiology of preterm birth is still lacking, necessitating the use of novel approaches to study pathogen invasion and progression in the pregnant mare. Such information may aid in the development of more targeted therapeutics for treatment of the afflicted mare and fetus.
Conventional methods, using in vivo models of infection to estimate bacterial numbers, are mainly based on harvesting and homogenization of infected tissues, serial plating of infectious agents, growing bacteria in cultures, and colony counting (Kuklin et al., 2003) . This is accompanied by further microbiological tests to identify the bacterium of interest to reduce the risk of false positives. These processes require extensive work, time, and resources in monitoring bacterial pathogenesis in vivo in experimentally induced infection studies (e.g., placentitis). In addition, diagnostic tools that can accurately and reliably identify at-risk pregnancies do not readily exist. One approach to better understand the pathogenesis of uterine and placental infections is the use of modified pathogens with the lux gene as a photonic biomarker and real-time bioluminescence imaging technology.
USE OF BIOLUMINESCENCE IMAGING TO MONITOR PATHOGEN PROGRESSION

Bioluminescence and Living Systems
Biophotonics involves the fields of optical imaging, photonics, and biology, and deals with the interactions among light, biological matter, and its application to biomedical science. Nature has harnessed the photon (i.e., light) in many ways as a basic principle of life, whether through photosynthetic pathways in plants, as methods of communication among insects (e.g., the firefly), or in a multitude of other examples from across the natural world. Bioluminescence is described as the voluntary or involuntary emission of visible light in living organisms (e.g., bacteria, fungi, fish, insects, algae, and squid), mediated by an enzyme catalyst (Meighen, 1993) . In general, the reaction that produces light involves a luciferase enzyme and a specific substrate that is oxidized to emit light (Doyle et al., 2004 ( )
The use of bioluminescence imaging in experimental models of human conditions has become a key diagnostic and research tool for understanding physiological systems in normal and disease states that were not previously attainable with other detection systems. The last 10 to 15 yr has seen unprecedented adaptations of this technology for investigating a variety of physiologically relevant systems in situ, including single cells (Willard et al., 1997 (Willard et al., , 1999 (Willard et al., , 2001 , whole plants (Anderson and Kay, 1995) , Drosphila (Brandes et al., 1996) , and rodents (Contag et al., 1995 (Contag et al., , 1997 Zhang et al., 2004; Ryan et al., 2005; Zinn et al., 2008) . Bioluminescent imaging technology using luciferase reporter genes to monitor physiological events in vivo has become an important and meaningful approach to studying biological responses in real time and over time, including the efficacy of drugs for cancer therapy, the pathogenesis of bacterial pathogens, or the regulation and expression of specific genes during specific physiological events (VoDinh, 2003; Klerk et al., 2007; Luker and Luker, 2008) .
Genetically Modified Bacteria with the Lux Gene
Conventional models to localize or estimate bacterial populations and invasiveness in vivo typically require extensive sampling procedures at each sampling time point and considerable time and labor to establish cultures (Curbelo et al., 2010) . A more recent approach has been the use of bacterial luciferases (e.g., photonemitting indicators) to label pathogens and monitor their progression during infections in rodents (Contag et al., 1995) . These luciferase-modified bacteria have been engineered by inserting a bacterially derived lux operon, which encodes for both the bacterial luciferase enzyme and a long-chain aldehyde substrate (Karsi et al., 2006) , resulting in the emission of visible light that can be detected using highly sensitive imaging systems. The bacterial luciferase differs from the firefly luciferase in that it catalyzes the oxidation of a long-chain aldehyde and reduced flavin mononucleotide to cause light emission (Karsi et al., 2006) .
The use of bioluminescence imaging allows biological processes associated with the infected state of eukaryotic cells to be monitored longitudinally, in vitro and in vivo, in real time and noninvasively (Contag, 2002) . The lux operon has been modified for bacterial incorporation by using plasmids, via transposon mutagenesis and chromosomal insertion, and the inserted operon routinely carries antibiotic resistance selection markers for cultivation as monocultures under controlled environmental conditions (Herrero et al., 1990) . For example, E. coli MM294 (no. 33625; American Type Culture Collection, Manassas, VA) has been modified with pAK1-lux plasmid, which contains an antibiotic-resistant gene cassette combined with the lux gene (Moulton et al., 2008 (Moulton et al., , 2009c . The plasmid (11,904 bp) used in this instance is a broad-host-range cloning vector with numerous plasmid replicons containing the lux operon (Frackman et al., 1990) . The lux operon itself is a cluster of genes (luxCDABE) isolated from a nematode symbiont bacterium Xenorhabdus luminescens and encodes for the bacterial luciferase and the biosynthetic enzymes for the proper substrate (Karsi et al., 2006) . Alternatively, E. coli has also been conferred with bioluminescent properties by incorporating the lux genes of Photorhabdus luminescens into its chromosome (e.g., lux operon in E. coli-Xen14, Caliper Life Sciences, Alameda, CA), which can then be selected for, using antibiotics to maintain pure cultures. In both cases (i.e., plasmid and chromosomal insertion), the lux operon system encodes all proteins required for photon emissions, including the luciferase, substrate, and substrate-regenerating enzymes (Luker and Luker, 2008) . However, the chromosomal insertion, compared with plasmid integration, exhibits a continuous and stable luciferase expression over time and without antibiotic pressure; theoretically, the lux genes incorporated in the bacterial chromosome should be as stable as their native chromosome genes (Herrero et al., 1990) . The use of bioluminescent bacteria, such as E. coli-pAK1-lux or E. coli-Xen14, coupled with bioluminescence imaging technologies, may represent an efficient model for achieving a greater understanding of the pathogenesis of uterine and placental infections in domestic species. Some studies have established positive relationships between bioluminescent signals and bacterial populations for gram-negative bacteria (r = 0.99; Kadurugamuwa et al., 2005) , whereas other investigators have described and validated bioluminescent bacterial models, both in vitro (Moulton et al., 2006 (Moulton et al., , 2009c and ex vivo (Moulton et al., 2009a,d; Curbelo et al., 2010) . More recently, studies have reported the use of bioluminescent reporters and biophotonic imaging technology to study mechanisms of pathogenesis of such pathogens as Staphylococcus aureus (Kuklin et al., 2003) , Aspergillus fumigatus (Brock et al., 2008) , Listeria monocytogenes (Konjufca and Miller, 2009 ), E. coli (Foucault et al., 2010) , and Mycobacterium tuberculosis (Andreu et al., 2010) ; however, these studies have focused on the use of the mouse model.
Others have used bioluminescent imaging technology to monitor the in vivo colonization and clearance dynamics of pathogens by light-emitting bacteria (i.e., E. coli) in living animals (Wiles et al., 2009; Foucault et al., 2010) . In addition, bioluminescent imaging and light-emitting bacteria (i.e., S. aureus) have been used to count and assess bacteria in biofilm and bacterial susceptibility tests of different graft materials (Lorenz et al., 2010) . Moreover, human drugs can now be screened in mouse models infected with light-emitting bacteria (Kuklin et al., 2003; Brock et al., 2008; Rando et al., 2010) , and it may be possible to explore the use of this technology in domestic species given that the appropriate research facilities are available to conduct such studies.
Bioluminescence Imaging of Pathogens in Domestic Species
Recent applications of bioluminescent paradigms in domestic animal models, including swine and sheep (Moulton et al., 2009a,d) , and the development of methods to facilitate deep tissue photon capture (e.g., optical clearing techniques; Moulton et al., 2006) across tissues (i.e., skin and intestine) indicate that in vivo imaging, as opposed to ex vivo or postmortem imaging, may be feasible in the near future by using minimally invasive detection procedures. Investigators have demonstrated the benefits of using genetically modified bacteria with the lux operon and bioluminescence imaging technology to improve our knowledge of the pathophysiology of diseases that affect farm animals economically. For instance, Moulton et al. (2009d) monitored in real time in situ pathogen progression of bioluminescent Salmonella in the gastrointestinal tract of swine. Studies have also evaluated fetal lambs delivered to bioluminescent E. coli-infected ewes ex vivo (Moulton et al., 2009a,b) and detection of bioluminescent E. coli within the excised bovine reproductive tract (Curbelo et al., 2010) . Others have used the same approach for noninvasive disease monitoring (Edwardsiella ictaluri) in living fish (Karsi et al., 2006) . Through further development of the paradigm outlined in the studies reported above, applications might be extended to provide a more resolved model for understanding the progression of events (e.g., bacterially induced endocrine changes, bacterial invasiveness of the fetal environment, or both) that leads to preterm delivery and pregnancy failure in mares, and may have applications for evaluating therapeutic interventions, with the goal of reducing antenatal mortality (Ryan et al., 2010b) .
Bioluminescence Imaging of Pathogens in the Mare
A small number of studies using experimental infectious conditions have been undertaken to better understand placental pathogenesis and more appropriate therapeutic regimens of late-term uterine infections that lead to abortion or preterm delivery in the mare (McGlothlin et al., 2004; Morris et al., 2007; Ryan et al., 2009; Bailey et al., 2010) . However, the application of bioluminescence imaging technology and the ability to modify pathogens with the lux gene provides investigators a unique opportunity to study the etiology of preterm delivery in the mare. The infectious experimental pony mare model developed by McGlothlin et al. (2004) was a starting point for our group to explore this approach. It has been proposed that the use of bacteria modified to express light and bioluminescent imaging technology may offer animal and veterinary researchers a useful means for understanding the pathogenesis of infectious pathogens leading to uterine infections and preterm delivery in the mare (Ryan et al., 2010b) . Initial in vitro feasibility studies were performed with excised reproductive tracts from mares sent to necropsy to determine the ability of the imaging system to detect light from photon-emitting lux-transformed bacteria through uterine tissue. These studies followed the FASS (2010) Guide for the Care and Use of Animals in Agricultural Research and Teaching and were approved by the Mississippi State University Institutional Animal Care and Use Committee. Figure 1 is an example of phontonic images derived from the ex vivo equine reproductive tract with bioluminescent E. coli-lux-filled balloons placed in the body of the uterine horns. These images demonstrate that it is feasible to detect the presence of the pathogen through the uterine wall and that the intensity of light emissions corresponds to the number of light-emitting bacteria placed inside the uterine horn.
To explore the practicality of infecting mares in vivo with light-emitting pathogens to better understand preterm delivery in mares with uterine infections, Ryan et al. (2010a) inoculated pony mares at approximately 300 d of gestation, via ultrasound-guided transvaginal injection into the amniotic cavity, with light-emitting E. coli-pAK1-lux. Mares maintained pregnancies from 24 to 48 h postinfection and then aborted fetuses. Intact fetuses were recovered immediately after abortion and were imaged for detection of lux-expressing bacteria. Images of an aborted fetus after bioluminescence imaging are shown in Figure 2a and 2b. The blue color represents the presence of light-emitting pathogens that have contaminated the amniotic fluid and, thus, the hair coat of the fetus. Yellow-red colors, indicative of greater bacterial colonization, can be detected in the region of the nares and sinuses and in the abdominal region representing sites along the gastrointestinal tract (Figure 2b ). Representative bioluminescent images are shown in Figure 3 of the contaminated fetal membranes of aborted fetuses and the localization of light-emitting pathogens in the nares, indicating that the pathogens are inspired by the fetus. To determine the presence of pathogens in specific organs, bacteria externally coating the fetuses were removed with a bleach bath to avoid contamination of the internal tissues. Subsequently, the heart, lungs, liver, bladder, gastrointestinal tract, and brain were removed and imaged. Imaging of excised tissues revealed heavy contamination not only of the lungs, but also of the gastrointestinal tract and kidneys, indicating that the pathogens were not only were imaged separately before insertion of the balloons into the uterus to acquire background measurements from the uterus (autobioluminescence) and total light emission from E. coli-pKA1-lux-filled balloons using an XR/MEGA-10Zero imaging system (Stanford Photonics Inc., Palo Alto, CA). All photonic images were acquired for 60 s and the results are expressed as relative light units per second (RLU/s). After imaging of the 2 balloons filled with light-emitting bacteria, the balloons were inserted separately into the empty uterus (panels C, E, and F) and reimaged. In these examples, the balloons filled with E. coli-pKA1-lux emitted 234.6 and 158.4 RLU/s (panels B and D, respectively), whereas the uterus on its own emitted 0.29 RLU/s. When the balloons were inserted into the uterus, the light emission values recorded were 32.6 (panel C), 0.46 (panel E), and 1.8 (panel F) RLU/s, yielding a transference of photonic emission of 13.9, 0.46, and 1.81%, respectively. The images shown in panels B to F are equivalent intensity of pseudocolor used for representation purposes. Photonic emission from Escherichia coli-pAK1-lux bacteria in excised organs from a preterm foal. The exposed cranial cavity of the fetal foal is shown in panel A. Note the presence of light-emitting bacteria in the nares and sinuses (arrows) but their absence from the cranial cavity and brain. Panel B shows the excised heart and lungs with light-emitting bacteria present only in the lungs but absent from the heart (arrow), whereas panel C shows the excised gastrointestinal tract with evidence of light in the stomach, small intestines (arrows), and large intestines. inspired but also ingested as the fetus consumed amniotic fluid (Figure 4 ).
An observation of particular interest was the presence of pathogens in the nares and sinuses of the fetus; however, no pathogens were observed in the brain when the cranial cavity was exposed (Figure 4a ). This is an interesting observation because of reports in the human literature that infants born to mothers diagnosed with chorioamnionitis are at increased risk of cerebral palsy (Grether and Nelson, 1997; Grether et al., 1999) and that increased fetal blood concentrations of IL-1β, IL-8, IL-9, TNFα (Nelson et al., 1998) , and interferons (Grether et al. 1999) have been reported in children with cerebral palsy, indicating a pathogen-induced increase in systemic proinflammatory cytokines. Other studies have demonstrated an association between intrauterine infections, increased fetal blood and neural tissue concentrations of proinflammatory cytokines, and incidence of cerebral tissue damage (Yoon et al., 1997 (Yoon et al., , 2003 Duggan et al., 2001) . Similar findings were observed in experimental studies with pregnant rats (Cai et al., 2000; Rodts-Palenik et al., 2004) . Whereas several studies have reported a greater incidence of septicemia in neonatal foals born to mares with uterine infections (Raisis et al., 1996; Gayle et al., 1998; Stewart et al., 2002) and that foals with increased serum TNFα activity had greater mortality rates (Morris and Moore, 1991) , no light-emitting bacteria were detected in the fetal foal brain (Ryan et al., 2010a) . Nevertheless, it is not clear at this point whether hypoxic ischemia encephalopathy (i.e., neonatal maladjustment foal syndrome) observed in foals that endure difficult deliveries might also be a consequence of in utero compromise of the fetus caused by placental insufficiency associated with uterine infections (i.e., placentitis). Recently, Wilcox et al. (2009) reported severe brain histopathology associated with placental insufficiency in a cloned foal consistent with that seen in preterm infants (Yoon et al., 1997 (Yoon et al., , 2003 Duggan et al., 2001 ) and in experimentally infected animal models, including rodent pups (Cai et al., 2000; Rodts-Palenik et al., 2004) and lambs (Moulton et al., 2009a) . Our experience with preterm foals born to dams experimentally infected during late gestation to induce placentitis (Ryan et al., 2009; Christiansen et al., 2010) supports the observation of Wilcox et al. (2009) , but the cerebral histopathology on such foals has yet to be completed. Applications that include the use of photon-emitting pathogens as a rapid biosensor of bacterial movements enable investigators to better understand the pathogen progression leading to preterm delivery and possibly improve on targeted antibacterial therapies in model systems (LeBlanc, 1997; Bailey et al., 2010; Christiansen et al., 2010) .
The ability to assess the postpartum clearance of bacteria after abortion and therapeutic intervention is another potentially valuable application of this technology (P. L. Ryan, D. L. Christiansen, K. Moulton, and F. K. Walters, unpublished data). A pilot study was performed in which 2 mares were infected intracervically (McGlothlin et al., 2004) with commercially available E. coli-lux-Xen14 (1.2 × 10 7 cfu; Caliper Life Sciences, Hopkinton, MA). After preterm delivery, mares were treated for 10 d postpartum with trimethoprim sulfamethoxazole (30 mg/kg, administered orally every 12 h). Sensitivity tests confirmed that the modified pathogen, E. coli-lux-Xen14, was sensitive to trimethoprim sulfamethoxazole. Uterine swabs and cervical fluid discharge samples were collected daily for culture from d 3 to 7 postpartum and again on d 10. Sterile examination sleeves used to recover uterine discharge samples revealed heavy contamination of light-emitting bacteria ( Figure 5 ), but contamination levels declined with time. Light-emitting bacteria were detected from uterine cultures of both mares on d 3 to 7 postpartum; however, contamination was observed to decrease markedly (6.0 × 10 8 to <1.0 × 10 3 cfu) over time and was negative by d 10 postpartum, consistent with the observed decrease in light emissions over the same period of time (Figures 6 and 7) . These studies are the first reported attempts to use lux-modified bacteria and bioluminescent imaging technology to better understand an economically important disease process in the horse. Although controlled hypothesis-driven studies are needed, the application of this technology in large domestic species is promising, notwithstanding the logistical and biological hazard challenges associated with such experimental animal models.
SUMMARY AND CONCLUSIONS
Recent applications of biophotonic paradigms in other domestic animal models [e.g., swine (Moulton et al., 2009d) , sheep (Moulton et al., 2009a) ] and the development of methods to facilitate deep-tissue photon capture (e.g., optical clearing techniques; Moulton et al., 2006) across tissues indicates that in vivo imaging, as opposed to ex vivo or postmortem imaging, using minimally invasive detection procedures may be feasible in the near future. Through further development of the paradigm outlined in the present report, applications might be extended to provide a more resolved model for understanding the progression of events (e.g., bacterially induced endocrine changes, bacterial invasiveness of the fetal environment) that lead to preterm delivery and pregnancy failure. Additionally, use of this technology may facilitate the development and evaluation of novel specific tissue-targeted therapeutic strategies to reduce or prevent antenatal mortality in equid species. In addition, the postpartum clearance of bacteria after abortion and subsequent therapeutic intervention are potentially valuable investigative applications for this technology. 
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